FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Bipartisan Bill to Lower Rx Drug Costs

Reps. Eric Sorensen and Stephanie Bice introduce bipartisan legislation to allow FDA to deny so-called sham citizen petitions filed by drug companies ...

latest-news-card-1
Medical Devices

Implantica Submits Final FDA Response for RefluxStop PMA

Implantica files the final response to FDA on its PMA for RefluxStop that addresses the agencys remaining questions tied to Module 3 of the device for...

latest-news-card-1
Medical Devices

Valar Labs Wins Breakthrough Status for AI Bladder Cancer Test

FDA grants Valar Labs a breakthrough device designation for its Vesta Bladder Risk Stratify Dx test.

latest-news-card-1
Medical Devices

FDA Approves Guardant Healths Next-Generation Guardant360 Liquid CDx

FDA approves Guardant Healths next-generation Guardant360 Liquid CDx, a blood-based comprehensive genomic profiling test designed to provide both geno...

latest-news-card-1
Biologics

ImmunityBios Anktiva sBLA for Expanded Use Accepted by FDA

FDA accepts for review an ImmunityBio supplemental BLA seeking to expand the label for Anktiva (nogapendekin alfa inbakicept-pmln) in combination with...

latest-news-card-1
Human Drugs

CGMP Deviations at Hangzhou Yiqi Biotechnology

FDA warns Chinas Hangzhou Yiqi Biotechnology Co. about CGMP deviations in its manufacturing of active pharmaceutical ingredients.

latest-news-card-1
Medical Devices

TEMPO Digital Health Pilot FAQs

FDA publishes frequently asked questions covering eligibility, statement of interest, and selection of participants for the TEMPO digital health pilot...

latest-news-card-1
Human Drugs

Harbin Jixianglong Biotech API Deviations

FDA warns Chinas Harbin Jixianglong Biotech about CGMP deviations and other violations in its manufacturing of active pharmaceutical ingredients.

Medical Devices

Staff Up for Breakthrough Device Recall Oversight: Post

A Stanford Law School Center for the Law and Biosciences fellow says policymakers should consider the growth in breakthrough medical devices cleared t...

latest-news-card-1
Human Drugs

Bayer Gets Priority Review for Stroke Drug

FDA grants Bayer a priority review for its NDA for asundexian, an investigational oral Factor XIa inhibitor designed to reduce the risk of recurrent s...